Skip to main content

Cholesterol rethink for high-risk patients.

Publication ,  Journal Article
Published in: Med Lett Drugs Ther
May 10, 2004

Duke Scholars

Published In

Med Lett Drugs Ther

ISSN

0025-732X

Publication Date

May 10, 2004

Volume

46

Issue

1182

Start / End Page

37 / 39

Location

United States

Related Subject Headings

  • Risk Factors
  • Pharmacology & Pharmacy
  • Muscular Diseases
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • Coronary Disease
  • Clinical Trials as Topic
  • Cholesterol, LDL
  • Acute Disease
  • 3214 Pharmacology and pharmaceutical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Cholesterol rethink for high-risk patients. (2004). Med Lett Drugs Ther, 46(1182), 37–39.
Cholesterol rethink for high-risk patients.Med Lett Drugs Ther 46, no. 1182 (May 10, 2004): 37–39.
Cholesterol rethink for high-risk patients. Med Lett Drugs Ther. 2004 May 10;46(1182):37–9.
Cholesterol rethink for high-risk patients.Med Lett Drugs Ther, vol. 46, no. 1182, May 2004, pp. 37–39.
Cholesterol rethink for high-risk patients. Med Lett Drugs Ther. 2004 May 10;46(1182):37–39.

Published In

Med Lett Drugs Ther

ISSN

0025-732X

Publication Date

May 10, 2004

Volume

46

Issue

1182

Start / End Page

37 / 39

Location

United States

Related Subject Headings

  • Risk Factors
  • Pharmacology & Pharmacy
  • Muscular Diseases
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • Coronary Disease
  • Clinical Trials as Topic
  • Cholesterol, LDL
  • Acute Disease
  • 3214 Pharmacology and pharmaceutical sciences